CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

CeriBell, Inc.NASDAQ: CBLL

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $239K fell 28.7% year over year, behind the +3.0% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 17.9% from the prior quarter. Over 3 fiscal years it compounded at +39.2% a year.

Context

  • Depreciation & amortization amounted to 1.5% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -28.7% toward the trailing-twelve-month pace of +3.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$239K-17.9% QoQ
Last fiscal yearDec 2025
$1.34M+17.5% YoY
LTMMar 2026
$1.25M+3.0% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-28.7%——
1 year+17.5%——
3-year CAGR+39.2%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
1.34M USD
Year-over-year change
+17.5%
3-year CAGR
+39.2%

Depreciation & Amortization vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 depreciation & amortization of $1.25M is the 6th highest of the 7 companies compared; the peer median is $1.59M.
  • Its year-over-year change of +3.0% is the 4th highest of 7, against a peer median of +1.3%.
  • Depreciation & amortization amounts to 1.3% of revenue for CBLL, versus a peer median of 2.5%.
CBLL Competitors Peer median
Depreciation & Amortization for CBLL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LIVNLivaNova PLCLTM Sep 2026$48.5M -15.7%-10.1%3.2%
STIMNeuronetics, Inc.LTM Mar 2026$3.3M +36.1%+28.1%2.2%
BWAYBrainsWay Ltd.LTM Mar 2026$1.61M -12.9%+0.1%2.9%
NPCENeuroPace, Inc.LTM Mar 2026$1.57M -13.4%-13.3%1.6%
ECORelectroCore, Inc.LTM Mar 2026$1.53M +24.3%+41.1%4.4%
CBLLCeriBell, Inc.LTM Mar 2026$1.25M +3.0%+39.2%1.3%
CVRXCVRx, Inc.LTM Mar 2026$777K +15.6%+22.4%1.3%
Peer median (excluding CBLL) $1.59M+1.3%+11.3%2.5%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue25.92M45.23M65.44M89.06M
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.9%84.4%86.7%87.9%
Research & Development7.24M9M13.56M19.14M
Selling, General & Admin50.27M59.21M82.9M117.53M
Operating Expenses57.51M68.2M96.46M136.68M
Depreciation & Amortization497K847K1.14M1.34M
EBITDA(35.06M)(26.51M)(37.32M)(50.18M)
EBITDA Margin-135.3%-58.6%-57.0%-56.3%
Operating Income(36.02M)(30.04M)(39.71M)(58.4M)
Operating Margin-139.0%-66.4%-60.7%-65.6%
Interest Income0000
Interest Expense1.6M2.1M1.99M1.89M
Other Income / Expenses(1.14M)588K(746K)4.99M
Income Before Tax(37.16M)(29.45M)(40.46M)(53.41M)
Pre-Tax Margin-143.4%-65.1%-61.8%-60.0%
Income Tax Expense2K11K00
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Net Margin-143.4%-65.1%-61.8%-60.0%
EPS (Basic)(1.59)(1.26)(3.39)(1.46)
EPS (Diluted)(1.59)(1.26)(3.39)(1.46)
Weighted Avg Shares23.32M23.32M11.95M36.54M
Weighted Avg Shares (Diluted)23.32M23.32M11.95M36.54M

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.